drugset / Trial / NCT06260046
Effect of Sufentanil on the Postoperative Pain
RandomizedParallel-groupDouble-blindPrevention
Summary
This study is a randomized, controlled trial. A total of 48 patients will be randomized to receive sufentanil or remifentanil during robot-assisted nephrectomy surgery.
Timeline
- Start
- 2024-03-01
- Primary completion
- 2025-01-15
- Completion
- 2027-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Remifentanil | Small molecule | 0.5 ng/ml | — |
| Comparator | Remifentanil | Small molecule | 5 ng/ml | — |
| Subject | Sufentanil | Other / unclassified | 0.05 ng/ml | — |
| Subject | Sufentanil | Other / unclassified | 0.5 ng/ml | — |
Indications
No indication recorded.